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Summary. Background: The adapter proteins SLP-76 and
LAT have been shown to play critical roles in the activation
of PLCc2 in platelets downstream of GPVI/FcRc and the
C-type lectin receptor CLEC-2. SLP-76 is constitutively
associated with the adapter Gads in platelets, which also
binds to tyrosine phosphorylated LAT, thereby providing a
potential pathway of regulation of SLP-76. Objective: In the
present study, we have compared the role of Gads alongside
that of LAT following activation of the major platelet
glycoprotein receptors using mice deﬁcient in the two adapter
proteins. Results: Gads was found to be required for the
eﬃcient onset of aggregation and secretion in response to
submaximal stimulation of GPVI and CLEC-2, but to be
dispensable for activation following stronger stimulation of
the two receptors. Gads was also dispensable for spreading
induced through integrin aIIbb3 or the GPIb–IX–V complex.
Further, Gads plays a negligible role in aggregate formation
on collagen at an arteriolar rate of shear. In stark contrast,
platelets deﬁcient in the adapter LAT exhibit a marked
decrease in aggregation and secretion following activation of
GPVI and CLEC-2, and are unable to form stable aggregates
on collagen at arteriolar shear. Conclusions: The results
demonstrate that Gads plays a key role in linking the adapter
LAT to SLP-76 in response to weak activation of GPVI and
CLEC-2 whereas LAT is required for full activation over a
wider range of agonist concentrations. These results reveal
the presence of a Gads-independent pathway of platelet
activation downstream of LAT.
Keywords: CLEC-2, Gads, GPVI, LAT, platelet, signalosome,
SLP-76.
Introduction
Immunoreceptor-tyrosine-based-activation motifs (ITAMs)
are characterized by the presence of two YxxL/I motifs
separated by 6–12 amino acids and are present on the cytosolic
chains of a number of hematopoietic-speciﬁc immunoglobulin
receptors, including Fc receptors, T- and B-cell antigen
receptors (TCR and BCR), and the platelet collagen receptor
complex, GPVI–FcRc chain. This group of receptors signals
through Src family kinase-dependent phosphorylation of the
conserved tyrosines in the ITAM leading to recruitment of a
Syk family kinase via its tandem SH2 domains, and stimulation
of a downstream signaling cascade, which results in activation
of phospholipase C (PLC) c. A novel variation of this signaling
pathway has been described in which the C-type lectin family
receptors, CLEC-2, Dectin-1, and CLEC-9A, signal through
sequential activation of Src and Syk family tyrosine kinases
downstream of a single YxxL sequence [1–3].
Adapter proteins play a critical role in signaling by ITAMs
and the ITAM-like receptors described above by forming a
protein-scaffold that serves to recruit PLCc to the membrane.
This is illustrated by the role of the membrane adapter LAT
and the two cytosolic adapters, Gads (Mona/Grap2/GrpL/
Grf40) and SLP-76 in regulation of PLCc1 in T cells. Gads
binds constitutively to SLP-76 and associates with LAT upon
T-cell receptor (TCR) activation forming a LAT signalosome
that is critical for activation of PLCc1 [4]. Mice deﬁcient in
LAT and SLP-76 have a complete inhibition of pre-TCR
signaling, leading to an absence of circulating, mature T cells
[5,6]. Similarly, there is a complete loss of activation of PLCc1
by the TCR in LAT-deﬁcient or SLP-76-deﬁcient Jurkat cells
[7,8]. In contrast, there is a limited degree of signaling by the
pre-TCR in the absence of Gads, resulting in a reduced number
of mature T cells [9]. Furthermore, disruption of the interaction
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between SLP-76 and Gads has been shown to impair TCR
signaling in Jurkat cells by approximately 50% [10,11]. Thus,
there is an absolute requirement for LAT and SLP-76 in the
activation of PLCc1 by the TCR, whereas the role for Gads
can be partially bypassed.
The LAT signalosome plays an important role in the
activation of platelets by the platelet collagen receptor GPVI
and the C-type lectin receptor, CLEC-2. However, in contrast
to signaling through the TCR, a limited degree of activation of
PLCc2 is induced by both receptors in platelets deﬁcient in
LAT [2,12]. Furthermore, CLEC-2 is able to induce a partial
activation of PLCc2 in the absence of SLP-76, whereas this
adapter is critical for the activation of the phospholipase by
GPVI [2,13]. Thus, there are important differences in the roles
of LATand SLP-76 in signaling betweenGPVI andCLEC-2 in
platelets, and also with the TCR. Interestingly, SLP-76 is
required for activation of PLCc2 downstream of two other
major platelet glycoprotein receptors, integrin aIIbb3 and
GPIb–IX–V [14–16]. However, in both cases, it is controversial
as to whether this is mediated downstream of an ITAM-
containing protein.
Very little is known about the role of Gads in platelets. Gads
associates with SLP-76 in platelets and undergoes tyrosine
phosphorylation upon stimulation of GPVI by the synthetic
collagen, CRP [17]. In the only functional study using Gads-
deﬁcient platelets, Judd et al. [15] reported that Gads is
dispensable for a-granule secretion in platelets induced by a
high concentration of GPVI-speciﬁc agonist, convulxin,
whereas LAT is essential for this response. In contrast, the
same research group has shown that mutation of the Gads
binding site on SLP-76 impairs GPVI-induced platelet secre-
tion [18]. To deﬁnitively characterize the role of Gads in
platelets, we have carried out an extensive investigation
of Gads-deﬁcient platelets following activation by GPVI,
CLEC-2, integrin aIIbb3, and GPIb–IX–V.
Experimental procedures
Animals
Genetically modiﬁed mice deﬁcient in Gads [9] and LAT [5]
were bred as heterozygotes to generate knockouts and litter-
mate controls. LAT-deﬁcient mice were bred on a C57Bl6J
background. Gads-deﬁcient mice were bred on a Balb-c
background or backcrossed for seven generations onto a
C57Bl6J background.
Reagents
Rhodocytinwas puriﬁed fromCalloselasma rhodostoma venom
as previously described [19]. The a-phosphotyrosine mAb
4G10, a-SLP-76 pAb, a-Gads pAb, and a-LAT pAb were
fromUpstate Biotechnology Inc. (TCS Biologicals Ltd, Bucks,
UK). The a-Grb2 pAb was from Santa Cruz Biotechnology
(Heidelberg, Germany). All other reagents were from
previously described sources [20–23].
Platelet preparation
Venous blood from healthy drug-free volunteers was taken into
10% sodium citrate. Mouse blood was drawn from CO2
asphyxiated mice following isoﬂuorane anesthesia by portal
vein puncture and taken into 100 lL of acid citrate dextrose.
Washed human and mouse platelets were obtained by centri-
fugation using prostacyclin to prevent activation during the
isolation procedure [24]. Both sets of washed platelets were
resuspended inmodiﬁed Tyrodes buffer as previously described
[24]. Platelets were used at a cell density of 2 · 108 mL)1 for
aggregometry, 5 · 108 mL)1 for biochemical studies and
2 · 107 mL)1 for spreading assays.
Platelet aggregation and adenosine triphosphate secretion
Aggregation was monitored by light transmission using a Born
lumi-aggregometer (Chronolog, Havertown, PA, USA). Aden-
osine triphosphate (ATP) secretion was measured by the
addition of a luciferin/luciferase substrate/enzyme mix (Chro-
nolume) [24,25].
Flow adhesion studies
Mouse bloodwas drawn into sodium heparin (10 UmL)1) and
PPACK (40 lM). Glass capillary tubes (Camlab, Cambridge,
UK) were coated in the presence of 100 lg mL)1 Horm
collagen (Nycomed, Munich, Germany) for 1 h at room
temperature. The capillaries were washed and blocked with
phosphate buffered saline (PBS) containing 5 mg mL)1 of
heat-inactivated bovine serum albumin (BSA) for 1 h at room
temperature before being mounted on the stage of an inverted
microscope (DM IRB; Leica). Anticoagulated whole blood
was pre-incubated with 2 lM DiOC6 for 15 min at 37 C to
ﬂuorescently label the cells. It was then perfused through the
chamber for 4 min at a wall shear rate of 1000 s)1 at 37 C,
followed by washing for 3 min at the same shear rate with
modiﬁed Tyrodes buffer whilst ﬂuorescent images were
captured. Adherent cells were then ﬁxed with 3.7% parafor-
maldehyde for 30 min and imaged using differential interfer-
ence contrast (DIC) microscopy on a Zeiss Axiovert 200 M
microscope (Carl Zeiss Ltd, Welwyn Garden City, UK).
Immunoprecipitation and Western blotting
Washed platelets were pre-treated with 1 mM EGTA, 10 lM
indomethacin and 2 U mL)1 apyrase to inhibit platelet
aggregation, thromboxane A2 (TxA2) production and to block
adenosine 5-diphosphate (ADP), respectively. Platelets were
stimulated with agonists at 37 Cwith stirring at 1200 r.p.m. in
a Born lumi-aggregometer. Reactions were terminated by
addition of 2· ice-cold NP-40 lysis buffer. Platelet lysates were
pre-cleared and detergent insoluble debris was discarded [24]. A
small aliquot was dissolved with sodium dodecyl sulfate (SDS)
sample buffer for detection of total tyrosine phosphorylation.
Antibodies against PLCc2, Syk, SLP-76, LAT, Gads, Grb2 or
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an isotype control were added to the resultant supernatant and
incubated overnight. The proteins were immunoprecipitated by
addition of protein A-Sepharose or protein G-Sepharose
beads. Precipitated proteins or whole-cell lysates were sepa-
rated by SDS- polyacrylamide gel electrophoresis, electrotrans-
ferred, and Western blotted by the indicated antibodies.
Platelet spreading assay
Coverslips were coated with matrix proteins as previously
reported [26]. Platelets were spread on collagen for 45 min at
37 C in the presence of apyrase (2 UmL)1) and indomethacin
(10 lM) before washing with PBS followed by ﬁxation with
paraformaldehyde (3.7%). Platelets were imaged by DIC
microscopy on a Zeiss Axiovert 200 M microscope. Platelet
surface area was analyzed using ImageJ (NIH, Bethesda, USA)
[26].
Results
Gads is required for rapid onset of aggregation and secretion
by low concentrations of CRP
A role for Gads and LAT in supporting platelet aggregation
was investigated using knockout mice. The GPVI receptor
agonist, CRP, stimulated concentration-dependent aggrega-
tion, with a threshold at 0.1 lg mL)1 and a maximal response
at 1 lg mL)1 (not shown). In the absence of LAT, the dose–
response curve was moved approximately tenfold to the right,
such that a concentration of 10 lg mL)1 of CRP was required
to induce full aggregation, although it was notable that this
response was delayed in onset (Fig. 1A). In contrast, the dose–
response curve for aggregation to CRP was only slightly right-
shifted in the absence of Gads, although there was a clear delay
in the onset of response to lower concentrations of the synthetic
collagen. Similar observations were observed on Gads)/) mice
bred on aBalb/c background or on aC57Bl6J background (not
shown). In comparison, aggregation induced by a low concen-
tration of the G protein-coupled receptor agonist thrombin
(0.03 U mL)1) was not signiﬁcantly different in the absence of
LAT or Gads (Fig. 1B).
We investigated the ability of the CLEC-2 receptor agonist,
rhodocytin, to stimulate aggregation in the absence of Gads
and LAT. We observed a delay and a reduction in aggregation
to low concentrations of rhodocytin (1–3 nM) in the absence of
Gads, although this effect was not seen with higher concen-
trations of the snake toxin (Fig. 1C). Similar results were
observed on Gads)/) mice bred on a Balb/c or C57Bl6J
background (not shown). In contrast, we observed a much
greater reduction in response to rhodocytin (3 nM) in LAT-
deﬁcient platelets, which could be overcome by a higher
concentration (30 nM), although a small delay in aggregation
could still be observed.
To investigate a role for Gads in dense granule secretion, we
monitored release of ATP using luciferin–luciferase. This
revealed a marked delay in the onset of secretion to CRP
(0.3–1 lg mL)1) in the absence of Gads, although full recovery
of response was seen over time (Fig. 1D). A similar pattern of
inhibition was observed for expression of the a-granulemarker,
P-selectin (not shown). In comparison, secretion of ATP
induced by CRP (1 lg mL)1) was abolished in LAT-deﬁcient
platelets, and markedly delayed at the higher concentration of
3 lg mL)1. There was also a reduction and delay in ATP
secretion induced by a low concentration of rhodocytin (1 nM)
inGads-deﬁcient platelets, although near full recovery was seen
at a higher concentration (Fig. 1E). In comparison, the
response to 3 nM rhodocytin was abolished in the absence of
LAT, with partial recovery observed in response to a higher
concentration (30 nM). The responses to low concentrations of
thrombin were not altered in the absence of Gads or LAT
(Fig. 1F).
Thus, the above observations demonstrate that Gads plays a
relatively minor role in mediating platelet activation by GPVI
and CLEC-2 in contrast to the greater role of LAT.
Spreading of Gads-deficient platelets on other matrix proteins
The above studies were extended to investigate the role of Gads
and LAT in spreading of platelets on ﬁbrinogen and von
Willebrand factor (VWF)/botrocetin, which is mediated
through activation of Syk downstream of integrin aIIbb3 and
GPIb–IX–V, respectively [26,27]. Platelets that have been
allowed to spread on ﬁbrinogen form ﬁlopodia and limited
lamellipodia, whereas platelets spread on VWF/botrocetin
form ﬁlopodia only. As shown in Fig. 2, there was no
signiﬁcant difference in the surface area or morphology of
control and Gads)/) and LAT)/) platelets that had been
allowed to spread on ﬁbrinogen or VWF/botrocetin.
Platelet aggregation on collagen at arteriolar rates of flow
Studies were designed to monitor platelet aggregation on
collagen at an arteriolar rate of ﬂow in platelets deﬁcient in
Gads or LAT. There was no detectable difference in the time
course or magnitude of platelet aggregation on collagen in the
absence of Gads relative to control platelets (Fig. 3). In
comparison, LAT)/) platelets formed a monolayer on collagen
but were unable to form platelet aggregates. This can be
explained by the limited degree of platelet activation giving rise
to stable adhesion, whereas secretion is required for subsequent
recruitment and activation of platelets.
Measurement of protein tyrosine phosphorylation in Gads-
deficient platelets
The above results reveal a minor role for Gads in supporting
platelet aggregation and secretion downstream of GPVI and
CLEC-2. To investigate the molecular basis of this, we
measured tyrosine phosphorylation of the key signaling
proteins, Syk, SLP-76, and PLCc2. There was a small but
consistent reduction in tyrosine phosphorylation of Syk, SLP-
76, and PLCc2 induced by CRP in the absence of Gads
2154 C. E. Hughes et al
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Fig. 1. Gads is required for rapid onset of aggregation and secretion by low concentrations of CRP and rhodocytin. Washed mouse platelets
(2 · 108 mL)1) were stimulated in an aggregometer with CRP (A), thrombin (B) or rhodocytin (C) and allowed to aggregate. Percentage light transmission
was calculated. Washed mouse platelets (2 · 108 mL)1) were stimulated in an aggregometer with CRP (D), rhodocytin (E) or thrombin (F) and
allowed to aggregate for 2 min. Adenosine triphosphate secretion was measured using light emission from luciferin/luciferase. Results are representative
of between three and eight experiments.
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(Fig. 4A), consistent with a supporting role for Gads in
mediating activation of PLCc2. In comparison, there was a
marked inhibition of phosphorylation of all three proteins in
the absence of LAT in response to CRP, as previously reported
[12]. There was also a minor reduction in phosphorylation of
SLP-76 and PLCc2 in Gads)/) platelets in response to
rhodocytin, although phosphorylation of Syk was not altered
(Fig. 4B). Phosphorylation of all three proteins induced by
rhodocytin was inhibited in the absence of LAT. These results
are in line with those for aggregation and secretion, with minor
and major roles for Gads and LAT, respectively, in regulat-
ing phosphorylation of PLCc2 downstream of GPVI and
CLEC-2.
Immunoprecipitation of Gads and Grb2
The relatively minor role of Gads in mediating platelet
activation by CRP and rhodocytin raises the issue of whether
there is a Gads-related protein that supports platelet activation
downstream of GPVI and CLEC-2 through binding to LAT.
Gads belongs to a family of three adapters, but only one other
of these is expressed in platelets, namely Grb2, which is also
known to bind to LAT [28]. To compare the roles of Gads and
Grb2, both proteins were immunoprecipitated from basal and
CRP-stimulated platelets and samples analyzed for protein
tyrosine phosphorylation (Fig. 5). Tyrosine phosphorylated
bands of 38 and 76 kDa, which co-migrate with LAT and SLP-
76, respectively, were observed to immunoprecipitate with
Gads, along with a band of 45 kDa that was detected after
90 s, and which co-migrates with a band that has previously
been identiﬁed as Gads [17]. Two further, unidentiﬁed tyrosine
phosphorylated bands of 60 and 150 kDa were also present. In
comparison, a major tyrosine phosphorylated band of 38 kDa
that co-migrates with LAT is observed in the Grb2 immuno-
precipitates, along with a weakly tyrosine phosphorylated band
of 76 kDa that co-migrates with SLP-76. There is also a
prominent tyrosine phosphorylated band of 125 kDa that has
not been identiﬁed. Conﬁrmation that the 38 and 76 kDa
bands correspond to LAT and SLP-76 was achieved by
immunoprecipitation of both proteins and Western blotting
(not shown).
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Fig. 2. Spreading of Gads-deficient and LAT-deficient platelets to other
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Fig. 3. Adhesion of Gads-deficient platelets on collagen under flow conditions. Heparinized whole mouse blood was passed through collagen-coated glass
capillaries at an intermediate shear rate of 1000 s)1. Platelets were ﬁxed and subsequently imaged by diﬀerential interference contrast (DIC) microscopy
(upper). Platelets were labeled ﬂuorescently with DiOC6 and imaged with a ﬂuorescent microscope (lower). Results are representative of ﬁve experiments.
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Discussion
The present study was undertaken with the primary goal of
comparing the roles of Gads and LAT in the regulation of
PLCc2 by platelet glycoprotein receptors, with particular
emphasis on the collagen receptor GPVI and the C-type lectin
receptor CLEC-2. In agreement with previous studies, LAT
was demonstrated to be critical for GPVI-mediated aggrega-
tion and secretion, with only high concentrations of CRP
inducing aggregation in the LAT)/) mice. Further, LAT)/)
platelets form a monolayer but are unable to aggregate when
ﬂowed over collagen at an arteriolar rate of ﬂow, consistent
with the critical role for dense granule secretion in mediating
aggregate development [29,30]. LAT is also critical for secretion
and aggregation induced by low concentrations of the CLEC-2
ligand rhodocytin, whereas recovery is seen at higher concen-
trations. However, LAT does not play a role in signaling by
integrin aIIbb3 or GPIB–IX–V. In comparison, Gads has a
minor role in mediating platelet activation by GPVI and
CLEC-2, as illustrated by the delay in onset and reduction in
aggregation and secretion following activation by low but not
high concentrations of CRP and rhodocytin, respectively.
Further, Gads does not mediate spreading by integrin aIIbb3
and GPIb–IX–V, although this is not surprising, given the lack
of a role for LAT in this event. Thus, these results illustrate a
differential role for LAT and Gads in supporting platelet
activation by GPVI and CLEC-2, whereas neither plays a role
in mediating spreading induced by integrin aIIbb3 and GPIb–
IX–V.
The minor role for Gads in supporting GPVI signaling in
platelets is in line with its more limited role in TCR signaling
relative to that of LAT and SLP-76. For example, mice
deﬁcient in Gads have a marked reduction in mature T cells [9]
as a consequence of inhibited pre-TCR signaling, whereas mice
deﬁcient in LAT and SLP-76 have no circulating T cells.
Further, mutation of the site of interaction of Gads with LAT
reduces signaling through the T-cell receptor by approximately
50% [28] in contrast to the full inhibition of T-cell signaling
that is observed in the absence of LAT and SLP-76 [7,8]. Thus,
Gads plays a relatively minor role in both platelets and T cells
in comparison with that of LAT and SLP-76, and its major
function may be to facilitate the interaction of the two adapter
proteins in response to low, threshold levels of receptor
stimulation. In theory, the breeding of mice that are deﬁcient
in bothGads and LAT is required to conﬁrm a role forGads in
the regulation of LAT in that a similar level of inhibition
should be seen in mice platelets deﬁcient in LAT to those
deﬁcient in LAT and Gads. However, the relatively small
phenotype observed in the absence of Gads would render it
difﬁcult to obtain an unequivocal answer on this.
Platelets express the Gads-related adapter, Grb2, which also
binds to LAT and SLP-76. This raises the possibility that a role
for Gads could be masked by the presence of Grb2, especially
in light of studies in aDT40 cell model reporting that Gads and
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Grb2 are both able to couple LAT and SLP-76, albeit that
Gads does this more efﬁciently [31]. Indeed, this is consistent
with the present result, which demonstrates that Grb2 associ-
ates strongly with LAT but only weakly with SLP-76, whereas
Gads is constitutively associated with SLP-76 (not shown). The
strong binding of Grb2 to LAT is explained by the presence of
three sites for association of Grb2 with LAT at phosphotyro-
sines Y171, Y191, and Y226 [28,32,33], compared with a single
site for Gads at phosphotyrosine Y191, and to a lesser extent
Y171 [28,32,33]. However, the increased binding of Gads to
SLP-76 is explained by the very high afﬁnity of the association
between the C-terminal SH3 domain of Gads and a RxxK
motif on SLP-76 of 3 nM [34,35]. This is an atypical interaction,
as the majority of SH3 domains bind to proline rich sequences
with micromolar afﬁnity, including the C-terminal SH3
domain of Grb2, which binds to a proline rich region in
SLP-76 with an afﬁnity of 3 lM [34].
Overall, the present observations and previous data empha-
size that SLP-76 and LAT are the key adapters in bringing
PLCc2 to the membrane, with SLP-76 being essential for
tyrosine phosphorylation and activation of the phospholipase.
In the absence of LAT, a limited degree of tyrosine phosphor-
ylation activation of PLCc occurs, which is sufﬁcient to enable
recovery of aggregation to high concentrations of CRP in the
absence of shear. However, platelet aggregation on collagen at
arteriolar shear is abolished in the absence of LAT (present
results) resulting in increased tail-bleeding and impaired
thrombus formation in vivo [36]. Interestingly, a reduction in
tyrosine phosphorylation of Syk was also observed in the
absence of LAT in platelets stimulated by CRP and rhodocy-
tin. This reduction is most likely due to increased accessibility
of tyrosine residues in Syk to protein tyrosine phosphatases in
the absence of LAT. In addition, however, we have also
identiﬁed a novel positive feedback role for Syk inmediating its
own phosphorylation in rhodocytin-stimulated platelets, which
also contributes to this reduction in phosphorylation (Spalton
JC, Watson SP, unpublished).
In comparison to LAT and SLP-76, Gads has a relatively
minor role in recruiting SLP-76 to LAT and activation of
PLCc2, and does not contribute to platelet aggregation at
arteriolar shear. Indeed, it may be that the evolution of a role
for Gads in mediating the interaction between LAT and SLP-
76 has occurred because of its role in facilitating weak signaling
by the pre-TCR to ensure an optimal number of mature T cells
in the circulation rather than to facilitate TCR or platelet
activation at higher agonist concentrations. Consistent with
this theory, Gads can be bypassed in an active PLCc
signalosome as PLCc can be recruited to LAT through a
direct interaction between LAT Y132 and its N-terminal SH2
domain [37–39].
The differing dependency on LAT and SLP-76 in the GPVI
andCLEC-2 signaling cascades could reﬂect either the presence
of a LAT-like molecule in platelets or the presence of a LAT-
independent pathway of recruitment of SLP-76 to the mem-
brane.The present study does not distinguish between these two
possibilities.However, ina related lineofwork in the laboratory,
we have been unable to ﬁnd evidence for a functional role of the
known LAT-like adapters in mediating platelet activation by
GPVI (Pearce AC, Schraven B, Hughes CE, Watson SP,
unpublisheddata).Thus,we favoramodel inwhichSLP-76and
PLCc2 are able to interact at the membrane independent of a
LAT-like membrane adapter protein, with Gads and LAT
having evolved to increase themagnitude of signaling. Thus, the
mechanism of activation of LAT-deﬁcient platelets by GPVI
and CLEC-2 may be similar to that used by integrin aIIbb3 and
GPIb–IX–V, which induce relatively weak activation through
LAT-independent, SLP-76-dependent activation of PLCc2.
In conclusion, the present study has demonstrated that the
adapter Gads plays a minor role in mediating platelet
activation by GPVI and CLEC-2, emphasizing an alternate
pathway through which LAT and SLP-76 regulate PLCc2.
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